Bi-directional drug-microbiome interactions of anti-diabetics (Q90555954)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30553752 AND SRC:MED&resulttype=core&format=json

14 April 2020

2 references

27 October 2020

4 February 2021

Bi-directional drug-microbiome interactions of anti-diabetics (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30553752 AND SRC:MED&resulttype=core&format=json

14 April 2020

2 references

27 October 2020

4 February 2021

anti-diabetic medication

1 reference

27 October 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30553752 AND SRC:MED&resulttype=core&format=json

14 April 2020

author name string

Andrew Whang

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30553752 AND SRC:MED&resulttype=core&format=json

14 April 2020

Ravinder Nagpal

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30553752 AND SRC:MED&resulttype=core&format=json

14 April 2020

publication date

13 December 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30553752 AND SRC:MED&resulttype=core&format=json

14 April 2020

1 January 2019

2 references

27 October 2020

4 February 2021

3 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30553752 AND SRC:MED&resulttype=core&format=json

14 April 2020

27 October 2020

4 February 2021

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30553752 AND SRC:MED&resulttype=core&format=json

14 April 2020

page(s)

591-602

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30553752 AND SRC:MED&resulttype=core&format=json

Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International

14 April 2020

copyright license

2 references

27 October 2020

Effects of a glucoside-hydrolase inhibitor (Bay g 5421) on serum lipids, lipoproteins and bile acids, fecal fat and bacterial flora, and intestinal gas production in hyperlipidemic patients

4 February 2021

cites work

1 reference

12 December 2020

Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers

1 reference

12 December 2020

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

1 reference

12 December 2020

Voglibose (AO-128) is an efficient alpha-glucosidase inhibitor and mobilizes the endogenous GLP-1 reserve

1 reference

12 December 2020

Acarbose, a pseudooligosaccharide, is transported but not metabolized by the maltose-maltodextrin system of Escherichia coli

1 reference

12 December 2020

Improved glycaemic control with miglitol in inadequately-controlled type 2 diabetics

1 reference

12 December 2020

Identification, cloning, expression, and characterization of the extracellular acarbose-modifying glycosyltransferase, AcbD, from Actinoplanes sp. strain SE50.

1 reference

12 December 2020

Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats.

1 reference

12 December 2020

Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor

1 reference

12 December 2020

Biotechnology and molecular biology of the alpha-glucosidase inhibitor acarbose

1 reference

12 December 2020

XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients

1 reference

12 December 2020

PPARs: therapeutic targets for metabolic disease

1 reference

12 December 2020

Vinegar supplementation lowers glucose and insulin responses and increases satiety after a bread meal in healthy subjects.

1 reference

12 December 2020

Obesity alters gut microbial ecology

1 reference

12 December 2020

Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes

1 reference

12 December 2020

Effect of Dahi containing Lactococcus lactis on the progression of diabetes induced by a high-fructose diet in rats

1 reference

12 December 2020

TLR4 links innate immunity and fatty acid-induced insulin resistance

1 reference

12 December 2020

Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats

1 reference

12 December 2020

Innate immunity modulates adipokines in humans.

1 reference

12 December 2020

Metabolic endotoxemia initiates obesity and insulin resistance

1 reference

12 December 2020

Biology of incretins: GLP-1 and GIP

1 reference

12 December 2020

Oral administration of dahi containing probiotic Lactobacillus acidophilus and Lactobacillus casei delayed the progression of streptozotocin-induced diabetes in rats

1 reference

12 December 2020

Dipeptidyl peptidase IV (DPP IV) and related molecules in type 2 diabetes

1 reference

12 December 2020

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

12 December 2020

A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance

1 reference

12 December 2020

Butyrate improves insulin sensitivity and increases energy expenditure in mice

1 reference

12 December 2020

Vinegar intake reduces body weight, body fat mass, and serum triglyceride levels in obese Japanese subjects

1 reference

12 December 2020

Sulfonylurea pharmacogenomics in Type 2 diabetes: the influence of drug target and diabetes risk polymorphisms

1 reference

12 December 2020

A sensitive liquid chromatography-electrospray tandem mass spectrometric method for lancemaside A and its metabolites in plasma and a pharmacokinetic study in mice

1 reference

12 December 2020

Metabolite profiles and the risk of developing diabetes

1 reference

12 December 2020

Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss

1 reference

12 December 2020

RETRACTED ARTICLE: Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii

1 reference

12 December 2020

Modulation of Mucosal Immune Response, Tolerance, and Proliferation in Mice Colonized by the Mucin-Degrader Akkermansia muciniphila.

1 reference

12 December 2020

Bifidobacterium adolescentis supplementation ameliorates visceral fat accumulation and insulin sensitivity in an experimental model of the metabolic syndrome

1 reference

12 December 2020

Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes.

1 reference

12 December 2020

Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women

1 reference

12 December 2020

Oral drug delivery systems using chemical conjugates or physical complexes

1 reference

12 December 2020

Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP

1 reference

12 December 2020

Cardiovascular effects of gliptins

1 reference

12 December 2020

The human gut microbiome and body metabolism: implications for obesity and diabetes

1 reference

12 December 2020

Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism.

1 reference

12 December 2020

Pharmacology, physiology, and mechanisms of incretin hormone action

1 reference

12 December 2020

Gut metagenome in European women with normal, impaired and diabetic glucose control

1 reference

12 December 2020

Consumption of cereal fiber, mixtures of whole grains and bran, and whole grains and risk reduction in type 2 diabetes, obesity, and cardiovascular disease

1 reference

12 December 2020

An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice

1 reference

12 December 2020

Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion.

1 reference

12 December 2020

Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: comparison, efficacy and safety

1 reference

12 December 2020

Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn's disease

1 reference

12 December 2020

Combining sitagliptin/metformin with a functional fiber delays diabetes progression in Zucker rats

1 reference

12 December 2020

Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits

1 reference

12 December 2020

Use of antidiabetic drugs in the U.S., 2003-2012.

1 reference

12 December 2020

The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism

1 reference

12 December 2020

Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase

1 reference

12 December 2020

Metabonomic study of biochemical changes in urinary of type 2 diabetes mellitus patients after the treatment of sulfonylurea antidiabetic drugs based on ultra-performance liquid chromatography/mass spectrometry

1 reference

12 December 2020

Gut microbiota-mediated drug interactions between lovastatin and antibiotics

1 reference

12 December 2020

Effect of metformin on metabolic improvement and gut microbiota

1 reference

12 December 2020

Acarbose treatment affects the serum levels of inflammatory cytokines and the gut content of bifidobacteria in Chinese patients with type 2 diabetes mellitus

1 reference

12 December 2020

Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice

1 reference

12 December 2020

Insights on the human microbiome and its xenobiotic metabolism: what is known about its effects on human physiology?

1 reference

12 December 2020

Dapagliflozin therapy in type-2 diabetes: current knowledge and future perspectives.

1 reference

12 December 2020

Dysbiosis of the gut microbiota in disease.

1 reference

12 December 2020

Short-Chain Fatty Acids Protect Against High-Fat Diet-Induced Obesity via a PPARγ-Dependent Switch From Lipogenesis to Fat Oxidation

1 reference

12 December 2020

Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats.

1 reference

12 December 2020

Gut Microbiota-Mediated Drug-Antibiotic Interactions

1 reference

12 December 2020

Interactions between Gut Microbiota, Host Genetics and Diet Modulate the Predisposition to Obesity and Metabolic Syndrome

1 reference

12 December 2020

Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats

1 reference

12 December 2020

Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota

1 reference

12 December 2020

Metformin and the gastrointestinal tract

1 reference

12 December 2020

Effect of probiotics on glucose metabolism in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials

1 reference

12 December 2020

Impact of Dietary Lipids on Colonic Function and Microbiota: An Experimental Approach Involving Orlistat-Induced Fat Malabsorption in Human Volunteers.

1 reference

12 December 2020

The Intestinal Microbiota in Metabolic Disease

1 reference

12 December 2020

Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome

1 reference

12 December 2020

Human gut microbes impact host serum metabolome and insulin sensitivity

1 reference

12 December 2020

Increased fecal viral content associated with obesity in mice

1 reference

12 December 2020

Microflora Disturbance during Progression of Glucose Intolerance and Effect of Sitagliptin: An Animal Study

1 reference

12 December 2020

Structural modulation of the gut microbiota and the relationship with body weight: compared evaluation of liraglutide and saxagliptin treatment

1 reference

12 December 2020

High-fat diet modifies the PPAR-γ pathway leading to disruption of microbial and physiological ecosystem in murine small intestine.

1 reference

12 December 2020

Response of gut microbiota and inflammatory status to bitter melon (Momordica charantia L.) in high fat diet induced obese rats.

1 reference

12 December 2020

A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice

1 reference

12 December 2020

Effects of Acarbose on the Gut Microbiota of Prediabetic Patients: A Randomized, Double-blind, Controlled Crossover Trial

1 reference

12 December 2020

Gut Microbial Diversity Assessment of Indian Type-2-Diabetics Reveals Alterations in Eubacteria, Archaea, and Eukaryotes.

1 reference

12 December 2020

Effect of miglitol on the suppression of nonalcoholic steatohepatitis development and improvement of the gut environment in a rodent model.

1 reference

12 December 2020

Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug

1 reference

12 December 2020

Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion

1 reference

12 December 2020

Mulberry leaf alleviates streptozotocin-induced diabetic rats by attenuating NEFA signaling and modulating intestinal microflora

1 reference

12 December 2020

High-Fat Diet Changes Fungal Microbiomes and Interkingdom Relationships in the Murine Gut.

1 reference

12 December 2020

Metformin Alters Upper Small Intestinal Microbiota that Impact a Glucose-SGLT1-Sensing Glucoregulatory Pathway

1 reference

12 December 2020

Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment.

1 reference

12 December 2020

Glitazones and alpha-glucosidase inhibitors as the second-line oral anti-diabetic agents added to metformin reduce cardiovascular risk in Type 2 diabetes patients: a nationwide cohort observational study

1 reference

12 December 2020

A human gut phage catalog correlates the gut phageome with type 2 diabetes.

1 reference

12 December 2020

SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice.

1 reference

12 December 2020

Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial.

1 reference

12 December 2020

The DPP-4 inhibitor vildagliptin impacts the gut microbiota and prevents disruption of intestinal homeostasis induced by a Western diet in mice

1 reference

12 December 2020

Understanding the Representative Gut Microbiota Dysbiosis in Metformin-Treated Type 2 Diabetes Patients Using Genome-Scale Metabolic Modeling.

1 reference

12 December 2020

10.1016/J.EBIOM.2018.11.046

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30553752 AND SRC:MED&resulttype=core&format=json

14 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30553752 AND SRC:MED&resulttype=core&format=json

14 April 2020

PubMed publication ID

30553752

1 reference